FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/08/027358 [Registered on: 24/08/2020] Trial Registered Prospectively
Last Modified On: 24/08/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparison of pain relieving efficacy of Dexmedetomidine, Fentanyl and Dexamethasone as an adjuvant to Ropivacaine in above the Collar bone Brachial plexus block (USG guided) when administered perineurally in adult patients undergoing upper limb surgery . 
Scientific Title of Study   Comparison of analgesic efficacy of Dexmedetomidine, Fentanyl and Dexamethasone as an adjuvant to Ropivacaine in Supraclavicular Brachial plexus block (USG guided) when administered perineurally in adult patients undergoing upper limb surgery : A randomized comparative study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pradeep Kumar Mulewa 
Designation  PG resident 3rd year 
Affiliation  Dr S. N Medical College 
Address  Office,deptt. Of anesthesia ,M.G hospital affiliated to Dr Sampurnanand Medical College, Jodhpur, Rajasthan

Jodhpur
RAJASTHAN
342001
India 
Phone  08005657338  
Fax    
Email  Pradeepmulewa@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vikas Rajpurohit 
Designation  Professor  
Affiliation  Dr S. N Medical College, Jodhpur 
Address  Trauma ICU ,MDM Hospital affiliated to Dr Sampurnanand Medical College, Jodhpur, Rajasthan

Jodhpur
RAJASTHAN
342001
India 
Phone  9928060011  
Fax    
Email  drvikasrajpurohit@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pradeep Kumar Mulewa 
Designation  PG resident 3rd year 
Affiliation  Dr S. N Medical College, Jodhpur 
Address  Department of Anaesthesia ,Dr Sampurnanand Medical College, Jodhpur, Rajasthan

Jodhpur
RAJASTHAN
342001
India 
Phone  08005657338  
Fax    
Email  Pradeepmulewa@gmail.com  
 
Source of Monetary or Material Support  
Dr Sampurnanand medical college ,jodhpur,Rajasthan 342001 
 
Primary Sponsor  
Name  Dr Sampurnanand Medical College Jodhpur 
Address  Dr Sampurnanand Medical college, jodhpur 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Pradeep kumar Mulewa  MDM Hospital, Dr Sampurnanand medical college jodhpur  Orthopaedics OT,MDM hospital,Dr Sampurnanand medical college jodhpur, rajasthan
Jodhpur
RAJASTHAN 
08005657338

Pradeepmulewa@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Dr Sampurnanand medical college, Jodhpur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Ropivacaine Dexmedetomidine Dexamethasone fentanyl   Ropivacaine 0.5% 30ML with Dexmedetomidine 100 mcg Ropivacaine 0.5% 30ML with Dexamethasone 8 mg Ropivacaine 0.5% 30ML with fentanyl 100mcg  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  All patients aged 20 to 60 years of either gender of ASA physical statue I and II undergoing upper limb surgery who willing to participate in the study. 
 
ExclusionCriteria 
Details  1. Patient refusal,
2. Hypersensitivity to amide local anaesthetics according to past history
3. Hypersensitivity to fentanyl, dexamethasone, dexmedatomidine infection at the injection site
4. Pregnant woman ( Urine Pregnancy Test positive)
5. Obesity (BMI >30kg/m2 )
6. Uncooperative patients
7. Anatomical abnormality at the site of injection
8. Bleeding disorders ( Deranged PT-INR , Clotting time and Bleeding time)
9. Peripheral neuropathy or neurological deficit ( Based on history of neurological disease and Clinical Neurological assessment- Fine Touch, Pin Test, Motor power)
10. Concurrent chronic analgesic therapy
11. Known hepatic or renal insufficiency( Deranged LFT, SGOT, SGPT, Serum Creatinine, Blood Urea)
12. Field block1. Patient refusal,
2. Hypersensitivity to amide local anaesthetics according to past history
3. Hypersensitivity to fentanyl, dexamethasone, dexmedatomidine infection at the injection site
4. Pregnant woman ( Urine Pregnancy Test positive)
5. Obesity (BMI >30kg/m2 )
6. Uncooperative patients
7. Anatomical abnormality at the site of injection
8. Bleeding disorders ( Deranged PT-INR , Clotting time and Bleeding time)
9. Peripheral neuropathy or neurological deficit ( Based on history of neurological disease and Clinical Neurological assessment- Fine Touch, Pin Test, Motor power)
10. Concurrent chronic analgesic therapy
11. Known hepatic or renal insufficiency( Deranged LFT, SGOT, SGPT, Serum Creatinine, Blood Urea)
12. Field block failure. failure. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the duration of analgesia produced in all three groups.  VAS Score analysis,blood pressure and heart rate before the procedure ,at the time of procedure and then every five minutes after the procedure. 
 
Secondary Outcome  
Outcome  TimePoints 
1) Onset of sensory block in minutes after the completion of block
2)Onset of motor block in minutes after the completion of block
3)Duration of motor block in hours until return of motor power
3)Haemodynamic parameters (heart rate, blood pressure,spo2) 
VAS Score analysis,blood pressure and heart rate before the procedure ,at the time of procedure and then every five minutes after the procedure. 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   24/08/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   We will compare the efficacy of ropivacaine and three other adjuvants drugs in ultrasound guided supraclavicular brachial plexus block in upper limp orthopaedic surgeries.  
Close